BridgeMD
New treatment option for Total Hip Arthroplasty (THA)
Official title Early Rehabilitation After Total Hip Arthroplasty
ClinicalTrials.gov ID: NCT07550647
What this study is testing
- What it's testing
- This study aims to investigate the effects of an early postoperative rehabilitation program combined with neuromuscular electrical stimulation (NMES) and telerehabilitation on functional recovery in patients undergoing total hip arthroplasty (THA). In the early postoperative period, patients commonly experience muscle weakness, impaired gait, and functional limitations that may delay recovery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 75
You may be able to join if
- Patients scheduled for unilateral total hip arthroplasty due to osteoarthritis or developmental dysplasia of the hip (DDH)
- Aged between 50 and 75 years
- Willing and able to participate in all follow-up assessments
- Able to comply with assessment procedures
- Able to meet the requirements of telerehabilitation
You likely can't join if
- Previous history of total hip arthroplasty on either side
- Planned revision total hip arthroplasty
- Severe osteoarthritis in the contralateral hip
- Presence of severe acute metabolic, neuromuscular, or cardiovascular disease
- History of active malignancy
- Presence of respiratory infection
See the full eligibility criteria
- Patients scheduled for unilateral total hip arthroplasty due to osteoarthritis or developmental dysplasia of the hip (DDH)
- Aged between 50 and 75 years
- Willing and able to participate in all follow-up assessments
- Able to comply with assessment procedures
- Able to meet the requirements of telerehabilitation
- Undergoing surgery with a standardized surgical protocol
- Previous history of total hip arthroplasty on either side
- Planned revision total hip arthroplasty
- Severe osteoarthritis in the contralateral hip
- Presence of severe acute metabolic, neuromuscular, or cardiovascular disease
- History of active malignancy
- Presence of respiratory infection
- Concomitant orthopedic conditions (e.g., lower extremity fractures, severe hip/knee deformities, lumbar or sacroiliac dysfunction)
- Body mass index \>35
- Occurrence of postoperative complications (e.g., prosthetic infection, thromboembolic events, or conditions requiring reoperation)
The study team makes the final eligibility decision.
Where it's taking place
- Niğde, Merkez, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Niğde, Merkez, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.